Abstract
Endostatin, cleaved from collagen XVIII in the extracellular matrix, is a promising circulating biomarker for cardiovascular damage. It possesses anti-angiogenic and anti-fibrotic functions and has even been suggested to be involved in blood pressure regulation. Less is known if endostatin levels relate to circadian blood pressure patterns. In the present paper we studied the association between circulating levels of endostatin and nocturnal dipping in blood pressure. We used the CARDIPP-study, a cohort of middle aged, type 2 diabetics (n = 593, 32% women), with data on both 24-hour and office blood pressure, serum-endostatin, cardiovascular risk factors, and incident major cardiovascular events. Nocturnal dipping was defined as a >10% difference between day- and night-time blood pressures. Two-hundred four participants (34%) were classified as non-dippers. The mean endostatin levels were significantly higher in non-dippers compared to dippers (mean ± standard deviation: 62.6 ± 1.8 µg/l vs. 58.7 ± 1.6 µg/l, respectively, p = .007). Higher serum levels of endostatin were associated with a diminished decline in nocturnal blood pressure adjusted for age, sex, HbA1c, mean systolic day blood pressure, hypertension treatment, glomeru...Continue Reading
References
Jun 1, 1979·Journal of Mental Deficiency Research·B W Richards, F Enver
Aug 13, 1988·Lancet·E O'BrienK O'Malley
Mar 1, 1996·American Journal of Hypertension·P GosseJ Clementy
Oct 6, 1999·Current Opinion in Cell Biology·C Streuli
Mar 16, 2000·The EMBO Journal·U FelborW Mothes
Mar 18, 2000·Hypertension·P Verdecchia
Jan 10, 2002·European Journal of Human Genetics : EJHG·T S ZorickM R Passos-Bueno
Nov 1, 2002·Journal of Hypertension·Takayoshi OhkuboYutaka Imai
Dec 17, 2004·Pharmacological Reviews·Ann HoebenErnst A De Bruijn
Jun 9, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Amir AbdollahiPeter E Huber
Jun 14, 2005·Experimental Cell Research·Ritva HeljasvaaraTaina Pihlajaniemi
Dec 27, 2005·Experimental Cell Research·Judah Folkman
Apr 1, 2006·Circulation Research·D WenzelB K Fleischmann
Oct 22, 2008·Hypertension·Michio FukudaGenjiro Kimura
Apr 25, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·E M DahlénC J Ostgren
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Oct 2, 2009·The Journal of Craniofacial Surgery·Sandra Ryeom, Judah Folkman
Mar 5, 2010·Current Diabetes Reviews·Cesare CuspidiCarla Sala
Nov 10, 2010·The American Journal of Cardiology·Christopher C DraheimDonald R Dengel
May 7, 2011·Primary Care Diabetes·Pär E son JennersjöCarl J Östgren
Dec 3, 2011·Journal of Hypertension·Chiara MarchesiAnna M Grandi
Jun 27, 2012·Proceedings of the National Academy of Sciences of the United States of America·Sarah B SunshineMaria Rupnick
Oct 9, 2012·Chronobiology International·Ramón C HermidaJosé R Fernández
Dec 19, 2012·Frontiers in Genetics·Bernard J van VarikLeon J Schurgers
Sep 14, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Johan ÄrnlövLars Lind
Oct 2, 2013·Hypertension·Axel C CarlssonJohan Arnlöv
Jan 7, 2014·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Yukie Yamaguchi, Carol A Feghali-Bostwick
Jan 8, 2014·Cardiovascular Diabetology·Michael SponderJeanette Strametz-Juranek
Nov 18, 2014·American Journal of Nephrology·Toralph RugeJohan Ärnlöv
Apr 18, 2015·Journal of Hypertension·Mohd S DramanEoin O'Brien
May 8, 2015·PloS One·Natalia Marek-TrzonkowskaJanusz Siebert
Feb 24, 2016·Hypertension·Gil F SallesGeorge C Roush
Apr 16, 2016·Diabetes & Metabolism·A C CarlssonJ Ärnlöv
Oct 27, 2016·Heart, Lung & Circulation·Benjamin B AlbertWayne S Cutfield
Sep 6, 2017·Journal of the Neurological Sciences·Georgios TsivgoulisEfstathios Manios
Oct 5, 2017·Biomarkers in Medicine·Toralph RugeJohan Ärnlöv